CRP and metabolic dysfunction-associated steatotic liver disease: CRP has been noted as a useful marker in distinguishing steatohepatitis from steatosis in NAFLD cases, and also, it was proposed as a promising prognostic biomarker for non-alcoholic steatohepatitis and the severity of its fibrosis [334,335,336,337,338,339].